1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Pretreatment tumor characteristics (n= 64)
Variable No. of Patients % of Total T classification T1 10 16 T2 30 47 T3 11 17 T4 13 20 N classification N0 51 80 N1 7 11 N2 6 9 Vocal cord mobility (left side) Normal 52 81 Impaired 7 11 Fixed 5 8 Vocal cord mobility (right side) Normal 56 87 Impaired 7 11 Fixed 1 2 Histopathology Well-differentiated 10 16 Moderately differentiated 43 67 Poorly differentiated 11 17